1. Home
  2. RGCO vs ANIK Comparison

RGCO vs ANIK Comparison

Compare RGCO & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RGC Resources Inc.

RGCO

RGC Resources Inc.

HOLD

Current Price

$23.72

Market Cap

233.9M

Sector

Utilities

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$15.87

Market Cap

200.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGCO
ANIK
Founded
1912
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.9M
200.9M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
RGCO
ANIK
Price
$23.72
$15.87
Analyst Decision
Hold
Buy
Analyst Count
1
1
Target Price
$22.70
$17.00
AVG Volume (30 Days)
11.8K
62.9K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
3.93%
N/A
EPS Growth
11.21
80.16
EPS
1.31
N/A
Revenue
$95,334,212.00
$112,819,000.00
Revenue This Year
$11.06
$5.98
Revenue Next Year
$2.89
$7.42
P/E Ratio
$17.95
N/A
Revenue Growth
12.63
N/A
52 Week Low
$19.68
$7.90
52 Week High
$26.63
$16.28

Technical Indicators

Market Signals
Indicator
RGCO
ANIK
Relative Strength Index (RSI) 55.88 63.50
Support Level $20.80 $13.88
Resistance Level $26.63 $15.93
Average True Range (ATR) 0.88 0.54
MACD -0.05 0.15
Stochastic Oscillator 29.92 77.57

Price Performance

Historical Comparison
RGCO
ANIK

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: